Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas.

@article{Chen2007ManagementOS,
  title={Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas.},
  author={Christine Yi-Chin Chen and Claire Hooper and Daniel Chiu and Matthew Kipp Chamberlain and Niral Karia and Wilson J. Heriot},
  journal={Retina},
  year={2007},
  volume={27 3},
  pages={321-8}
}
PURPOSE To evaluate the clinical outcome of intravitreal tissue plasminogen activator (tPA) and expansile gas injection as a minimally invasive treatment for submacular hemorrhage (SMH). METHODS This study was a retrospective clinical case series examining 104 eyes that received an intravitreal injection of 30-100 mcg of tPA and expansile gas (SF6 or C3F8) for SMH. The main outcomes evaluated were visual acuities (VA), anatomic displacement of submacular blood, and surgical complications… CONTINUE READING